Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Wave crashes after obesity trial tracks 1% dip in body weight
Investors drove the stock down more than 50% despite the biotech hailing the data as positive.
Nick Paul Taylor
Mar 26, 2026 9:20am
Innate's NK cell engager latest victim of pipeline refocus
Mar 26, 2026 5:20am
Avoiding 11th hour surprises in clinical trials
Brought to you by
Almac Clinical Services
OrbiMed-backed Pinnacle adds $89M for oral peptides
Mar 26, 2026 10:29am
How physiology powers biotech innovation
Brought to you by
American Physiological Society
CMR Surgical kicks off US commercial launch
Mar 26, 2026 12:20pm
More News
Philips AI cath lab copilot nets FDA clearance
Mar 26, 2026 10:45am
Pulmatrix picked for reverse merger with anti-aging biotech
Mar 26, 2026 10:12am
Biopharma funding fell 20% in 2025: IQVIA
Mar 26, 2026 6:01am
Fierce Pharma
FDA approves Denali's Hunter syndrome drug
Mar 25, 2026 2:50pm
See more stories
